|
In today's Daily Pitch, you'll find: | | | | | |
|
|
Why generative AI orchestration startups are poised for growth in 2024 | | | (Yuichiro Chino/Getty Images) | | | Plenty of startups have tried to bring generative AI to other companies—and plenty have stumbled along the way. Enter orchestration startups, which address some of the most pressing challenges in the space: choosing which large language model to use, integrating multiple models into a single service and deploying applications at low cost. These startups are poised to play a larger role as more companies look to put generative AI into action. | | | | | | December wrap-up: One month in global markets | | After strong returns across global markets, 2023 ended on a high note. Our latest Global Markets Snapshot breaks down a month of trends in the equity, debt and commodities markets, tracking returns across a range of indexes and sectors. It also features private market activity, including major deals, fundraising, IPO performance, lending volume and unicorn creation. In this monthly digest, we provide the datasets that the PitchBook Institutional Research Group is keeping an eye on as we start off the new year. | | | | | | |
|
|
2024 PitchBook Media Kit released | | Volatility is on the rise, everywhere. Dealmakers are looking for insights, services and tools to navigate challenging, complex market environments—and you can help them. By partnering with PitchBook Media, you can reach over two million industry professionals spanning the C-suite to flagship GP offices. Customize a unique array of options from the brand-new 2024 PitchBook Media Kit, including: - Sponsorship of market-leading reports such as the PitchBook-NVCA Venture Monitor
- Placement in the most widely read industry newsletters such as the Weekend or Credit Pitch
- Sponsored columns to share your specific message or thought leadership
- Bespoke research options for unique, in-depth analysis
Talk to us | | | | | | |
|
Building awareness on objects in our orbit | | Our recent Emerging Space Brief dives into the rapidly expanding industry of space situational awareness, which is the practice of monitoring, understanding and controlling objects in Earth's orbit. The industry landscape is shifting toward civilian control and, with it, new opportunities for commercialization. Some promising recent deals and a broader market outlook are profiled in our research. | | | | | | Enterprise Ireland topped list of Europe's most active VC investors | | | (Seng Kui Lim/Getty Images) | | | Enterprise Ireland participated in the most European venture rounds last year, even as the region's overall dealmaking has been relatively quiet. Take a look at the rest of European VC's top 10 investors of 2023. | | | | | | |
|
|
| Since yesterday, the PitchBook Platform added: | 509 Deals | 1789 People | 504 Companies | 29 Funds | | | | | |
|
The Daily Benchmark: 2017 Vintage Global Funds-of-Funds | | | | | |
|
|
New York-based biotech startup OnCusp Therapeutics secured $100 million in a Series A led by Novo Holdings, F-Prime Capital and OrbiMed. Generative AI startup Perplexity AI raised a $73.6 million Series B led by IVP. California's Moonwalk Biosciences, a genomic medicine company, raised $57 million in seed and Series A funding from investors including GV, Khosla Ventures and Arch Venture Partners. Bumper, a London-based provider of buy now, pay later payment options for car repairs, secured a $48 million Series B led by Autotech Ventures. Construction-tech startup Agorus, which is based in San Diego, is raising a $20 million Series A led by Toyota Ventures, Axios reported. Resalis Therapeutics, an Italian developer of treatments for metabolic diseases, raised a €10 million Series A led by Sunstone Life Science Ventures. | | | | | |
|
|
|
|
|
|
|
|
|
Bain Capital is contemplating a sale of Centrient Pharmaceuticals in a deal that could value the antibodies specialist at up to €1 billion, Bloomberg reported. Bain acquired Netherlands-based Centrient in 2018. | | | | | |
|
|
|
|
|
|
|
|
|
|
No comments:
Post a Comment